CONSTITUTIONAL ISOSEXUAL  PRECOCIOUS PUBERTY. EFFECTS OF MEDROXYPROGESTERONE ACETATE THERAPY.
D015068:17-Ketosteroids; D002648:Child; D004967:Estrogens; D006062:Gonadotropins; D006065:Gonadotropins, Pituitary; D006128:Growth; D006801:Humans; D008525:Medroxyprogesterone; D017258:Medroxyprogesterone Acetate; D010900:Pituitary Diseases; D010902:Pituitary Gland; D011276:Pregnanediol; D011379:Prognosis; D011627:Puberty; D011629:Puberty, Precocious; D012741:Sexual Maturation; D014556:Urine
D015068:17-Ketosteroids; D004967:Estrogens; D006062:Gonadotropins; D006065:Gonadotropins, Pituitary; D017258:Medroxyprogesterone Acetate; D008525:Medroxyprogesterone; D011276:Pregnanediol
17-KETOSTEROIDS; CHILD; ESTROGENS; GONADOTROPINS, PITUITARY; GROWTH; MEDROXYPROGESTERONE; PREGNANEDIOL; PROGNOSIS; PUBERTY, PRECOCIOUS; URINE